Pro Share Advisors LLC Sangamo Therapeutics, Inc Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$0.36 - $0.65 $2,451 - $4,427
-6,811 Reduced 25.45%
19,955 $7,000
Q1 2024

May 08, 2024
BUY
$0.42 - $1.38 $782 - $2,572
1,864 Added 7.49%
26,766 $17,000
Q4 2023

Feb 14, 2024
SELL
$0.3 - $0.63 $1,624 - $3,412
-5,416 Reduced 17.86%
24,902 $13,000
Q3 2023

Nov 13, 2023
BUY
$0.58 - $1.47 $256 - $651
443 Added 1.48%
30,318 $18,000
Q2 2023

Aug 10, 2023
BUY
$1.11 - $1.74 $2,712 - $4,252
2,444 Added 8.91%
29,875 $38,000
Q1 2023

May 11, 2023
SELL
$1.66 - $3.67 $5,546 - $12,261
-3,341 Reduced 10.86%
27,431 $48,000
Q4 2022

Feb 02, 2023
BUY
$2.77 - $5.07 $9,725 - $17,800
3,511 Added 12.88%
30,772 $96,000
Q3 2022

Nov 04, 2022
BUY
$4.27 - $6.39 $10,171 - $15,220
2,382 Added 9.57%
27,261 $134,000
Q2 2022

Aug 01, 2022
SELL
$3.28 - $6.21 $41,049 - $77,718
-12,515 Reduced 33.47%
24,879 $104,000
Q1 2022

May 10, 2022
SELL
$5.23 - $7.82 $47,373 - $70,833
-9,058 Reduced 19.5%
37,394 $217,000
Q4 2021

Feb 08, 2022
BUY
$7.29 - $10.97 $1,348 - $2,029
185 Added 0.4%
46,452 $348,000
Q3 2021

Nov 12, 2021
SELL
$9.01 - $12.01 $90,829 - $121,072
-10,081 Reduced 17.89%
46,267 $417,000
Q2 2021

Aug 13, 2021
BUY
$10.17 - $12.64 $58,579 - $72,806
5,760 Added 11.39%
56,348 $674,000
Q1 2021

May 14, 2021
BUY
$10.88 - $17.05 $35,425 - $55,514
3,256 Added 6.88%
50,588 $634,000
Q4 2020

Feb 09, 2021
BUY
$9.23 - $18.18 $96,878 - $190,817
10,496 Added 28.49%
47,332 $739,000
Q3 2020

Nov 13, 2020
SELL
$9.38 - $12.48 $12,428 - $16,536
-1,325 Reduced 3.47%
36,836 $348,000
Q2 2020

Aug 03, 2020
BUY
$6.21 - $11.83 $96,192 - $183,246
15,490 Added 68.33%
38,161 $342,000
Q1 2020

May 15, 2020
SELL
$5.05 - $8.85 $90,763 - $159,061
-17,973 Reduced 44.22%
22,671 $144,000
Q4 2019

Feb 12, 2020
SELL
$8.03 - $11.7 $30,136 - $43,910
-3,753 Reduced 8.45%
40,644 $340,000
Q3 2019

Nov 12, 2019
SELL
$9.05 - $12.22 $280 - $378
-31 Reduced 0.07%
44,397 $402,000
Q2 2019

Aug 13, 2019
SELL
$8.75 - $13.03 $11,217 - $16,704
-1,282 Reduced 2.8%
44,428 $478,000
Q1 2019

May 15, 2019
BUY
$7.72 - $12.81 $3,203 - $5,316
415 Added 0.92%
45,710 $436,000
Q4 2018

Feb 14, 2019
SELL
$9.51 - $16.6 $81,510 - $142,278
-8,571 Reduced 15.91%
45,295 $520,000
Q3 2018

Nov 14, 2018
SELL
$13.05 - $19.05 $28,044 - $40,938
-2,149 Reduced 3.84%
53,866 $913,000
Q2 2018

Aug 13, 2018
BUY
$13.9 - $19.8 $86,430 - $123,116
6,218 Added 12.49%
56,015 $795,000
Q1 2018

May 14, 2018
SELL
$16.7 - $26.35 $136,722 - $215,727
-8,187 Reduced 14.12%
49,797 $946,000
Q4 2017

Feb 14, 2018
BUY
$11.6 - $17.35 $60,238 - $90,098
5,193 Added 9.84%
57,984 $951,000
Q3 2017

Nov 13, 2017
BUY
$8.4 - $15.0 $80,304 - $143,400
9,560 Added 22.11%
52,791 $792,000
Q2 2017

Aug 11, 2017
BUY
N/A
43,231
43,231 $380,000

Others Institutions Holding SGMO

# of Institutions
111
Shares Held
56.7M
Call Options Held
576K
Put Options Held
1.17M
View Full List

About SANGAMO THERAPEUTICS, INC

SGMO Quotes by TradingView
  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $193M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email